SCHEMBL23073371

SCHEMBL23073371

O=c1[nH]nc(Cc2ccc(F)c(P3CCN(c4ncccn4)CC3)c2)c2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23073332 0.83 PARP1 (0.60) PARP1
SCHEMBL23064718 0.81 PARP1 (0.69) PARP1
SCHEMBL14233393 0.80 PARP1 (0.80) PARP1
SCHEMBL15917987 0.80 PARP1 (0.68) PARP1
SCHEMBL15917988 0.80 PARP1 (0.67) PARP1
SCHEMBL24113949 0.78 PARP1 (0.45) PARP1
SCHEMBL23073370 0.77 PARP1 (0.53) PARP1
SCHEMBL12955373 0.74 LMNA (0.68) PARP1
SCHEMBL15917661 0.73 PARP1 (0.83) PARP1
SCHEMBL15918645 0.73 PARP1 (0.83) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714703-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE NEWGEN THERAPEUTICS INC (US) 2021-03-10 — — EP disclosed
Send feedback